全文获取类型
收费全文 | 1548篇 |
免费 | 125篇 |
国内免费 | 35篇 |
出版年
2023年 | 23篇 |
2022年 | 51篇 |
2021年 | 73篇 |
2020年 | 43篇 |
2019年 | 51篇 |
2018年 | 62篇 |
2017年 | 52篇 |
2016年 | 65篇 |
2015年 | 77篇 |
2014年 | 97篇 |
2013年 | 107篇 |
2012年 | 141篇 |
2011年 | 138篇 |
2010年 | 75篇 |
2009年 | 57篇 |
2008年 | 91篇 |
2007年 | 73篇 |
2006年 | 56篇 |
2005年 | 55篇 |
2004年 | 34篇 |
2003年 | 32篇 |
2002年 | 31篇 |
2001年 | 19篇 |
2000年 | 20篇 |
1999年 | 21篇 |
1998年 | 19篇 |
1997年 | 9篇 |
1996年 | 7篇 |
1995年 | 2篇 |
1994年 | 4篇 |
1993年 | 9篇 |
1992年 | 15篇 |
1991年 | 7篇 |
1990年 | 9篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1987年 | 7篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1984年 | 2篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 3篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 6篇 |
1975年 | 2篇 |
1973年 | 5篇 |
1971年 | 6篇 |
排序方式: 共有1708条查询结果,搜索用时 109 毫秒
941.
Mai H. Oushy Rebecca Palacios Alan E. C. Holden Amelie G. Ramirez Kipling J. Gallion Mary A. O’Connell 《PloS one》2015,10(9)
Background
Cancer health disparities research depends on access to biospecimens from diverse racial/ethnic populations. This multimethodological study, using mixed methods for quantitative and qualitative analysis of survey results, assessed barriers, concerns, and practices for sharing biospecimens/data among researchers working with biospecimens from minority populations in a 5 state region of the United States (Arizona, Colorado, New Mexico, Oklahoma, and Texas). The ultimate goals of this research were to understand data sharing barriers among biomedical researchers; guide strategies to increase participation in biospecimen research; and strengthen collaborative opportunities among researchers.Methods and Population
Email invitations to anonymous participants (n = 605 individuals identified by the NIH RePORT database), resulted in 112 responses. The survey assessed demographics, specimen collection data, and attitudes about virtual biorepositories. Respondents were primarily principal investigators at PhD granting institutions (91.1%) conducting basic (62.3%) research; most were non-Hispanic White (63.4%) and men (60.6%). The low response rate limited the statistical power of the analyses, further the number of respondents for each survey question was variable.Results
Findings from this study identified barriers to biospecimen research, including lack of access to sufficient biospecimens, and limited availability of diverse tissue samples. Many of these barriers can be attributed to poor annotation of biospecimens, and researchers’ unwillingness to share existing collections. Addressing these barriers to accessing biospecimens is essential to combating cancer in general and cancer health disparities in particular. This study confirmed researchers’ willingness to participate in a virtual biorepository (n = 50 respondents agreed). However, researchers in this region listed clear specifications for establishing and using such a biorepository: specifications related to standardized procedures, funding, and protections of human subjects and intellectual property. The results help guide strategies to increase data sharing behaviors and to increase participation of researchers with multiethnic biospecimen collections in collaborative research endeavorsConclusions
Data sharing by researchers is essential to leveraging knowledge and resources needed for the advancement of research on cancer health disparities. Although U.S. funding entities have guidelines for data and resource sharing, future efforts should address researcher preferences in order to promote collaboration to address cancer health disparities. 相似文献942.
Mai Kimura Yuichi Tamura Makoto Takei Tsunehisa Yamamoto Tomohiko Ono Masataka Kuwana Keiichi Fukuda Toru Satoh 《PloS one》2015,10(4)
Background
Intravenous infusion (IVI) of epoprostenol is an effective treatment for patients with advanced pulmonary arterial hypertension (PAH). However, there is no widely accepted standard method for initiating the IVI therapy. This study evaluated the hemodynamic improvements achieved with IVI epoprostenol to determine the optimal protocol for treatment initiation.Methods and Results
We retrospectively analyzed 42 consecutive PAH patients who underwent IVI epoprostenol in Keio University Hospital from 2001 to 2013. The study group comprised 30 women with a mean age of 34.3 ± 1.9 years. The etiology of PAH was idiopathic or heritable PAH (I/HPAH) in 38 cases, PAH associated with connective tissue disease in 3, and Eissenmenger’s syndrome in the remaining case. We divided the patients into rapid- and slow-initiation therapy groups according to the cumulative epoprostenol dose administered during the first 180 days, and compared the hemodynamic changes between the groups. The median cumulative doses were 6142 ± 165 μg/kg and 3998 ± 132 μg/kg epoprostenol, respectively. While there were no significant differences in mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), or cardiac index (CI) between the groups before the IVI epoprostenol therapy, the rapid-initiation therapy group achieved significant improvements in these hemodynamic data compared with the slow-initiation therapy group (P < 0.005) at the follow-up right-heart catheterization (RHC).Conclusion
Rapid initiation of IVI epoprostenol therapy achieved the optimal hemodynamic improvements in patients with severe PAH. 相似文献943.
Bui The Hung Nguyen Phuoc Long Le Phi Hung Nguyen Thien Luan Nguyen Hoang Anh Tran Diem Nghi Mai Van Hieu Nguyen Thi Huyen Trang Herizo Fabien Rafidinarivo Nguyen Ky Anh David Hawkes Nguyen Tien Huy Kenji Hirayama 《PloS one》2015,10(4)
Background
Evidence-based medicine (EBM) has developed as the dominant paradigm of assessment of evidence that is used in clinical practice. Since its development, EBM has been applied to integrate the best available research into diagnosis and treatment with the purpose of improving patient care. In the EBM era, a hierarchy of evidence has been proposed, including various types of research methods, such as meta-analysis (MA), systematic review (SRV), randomized controlled trial (RCT), case report (CR), practice guideline (PGL), and so on. Although there are numerous studies examining the impact and importance of specific cases of EBM in clinical practice, there is a lack of research quantitatively measuring publication trends in the growth and development of EBM. Therefore, a bibliometric analysis was constructed to determine the scientific productivity of EBM research over decades.Methods
NCBI PubMed database was used to search, retrieve and classify publications according to research method and year of publication. Joinpoint regression analysis was undertaken to analyze trends in research productivity and the prevalence of individual research methods.Findings
Analysis indicates that MA and SRV, which are classified as the highest ranking of evidence in the EBM, accounted for a relatively small but auspicious number of publications. For most research methods, the annual percent change (APC) indicates a consistent increase in publication frequency. MA, SRV and RCT show the highest rate of publication growth in the past twenty years. Only controlled clinical trials (CCT) shows a non-significant reduction in publications over the past ten years.Conclusions
Higher quality research methods, such as MA, SRV and RCT, are showing continuous publication growth, which suggests an acknowledgement of the value of these methods. This study provides the first quantitative assessment of research method publication trends in EBM. 相似文献944.
Louise M. Stewart C. D’Arcy J. Holman James B. Semmens David Preen Qun Mai Roger Hart 《PloS one》2015,10(3)
Objective
To examine the association between in vitro fertilization (IVF) and later admission to hospital with a mental health diagnosis in women who remained childless after infertility treatment.Methods
This was a population-based cohort study using linked administrative hospital and registry data. The study population included all women commencing hospital treatment for infertility in Western Australia between the years 1982 and 2002 aged 20–44 years at treatment commencement who did not have a recorded birth by the end of follow-up (15 August 2010) and did not have a hospital mental health admission prior to the first infertility admission (n=6,567). Of these, 2,623 women had IVF and 3,944 did not. We used multivariate Cox regression modeling of mental health admissions and compared women undergoing IVF treatment with women having infertility treatment but not IVF.Results
Over an average of 17 years of follow-up, 411 women in the cohort were admitted to hospital with a mental health diagnosis; 93 who had IVF and 318 who did not. The unadjusted hazard ratio (HR) for a hospital mental health admission comparing women who had IVF with those receiving other infertility treatment was 0.50 (95% confidence interval [CI] 0.40–0.63). After adjustment for age, calendar year and socio-economic status the HR was 0.56 (95% CI 0.44–0.71).Conclusions
IVF treatment is associated with a reduced risk of hospital mental health admissions in women after unsuccessful infertility treatment. This may be explained by the healthy cohort effect. 相似文献945.
Bo Zhang Daniel Cowden Fan Zhang Jue Yuan Sandra Siedlak Mai Abouelsaad Liang Zeng Xuefeng Zhou John O'Toole Alvin S. Das Diane Kofskey Miriam Warren Zehua Bian Yuqi Cui Tao Tan Adam Kresak Robert E Wyza Robert B. Petersen Gong-Xian Wang Qingzhong Kong Xinglong Wang John Sedor Xiongwei Zhu Hua Zhu Wen-Quan Zou 《PloS one》2015,10(10)
946.
Mai Duong Rebekah J. Moles Betty Chaar Timothy F. Chen World Hospital Pharmacy Research Consortium 《PloS one》2015,10(12)
Objective
To explore the perspectives of a diverse group of stakeholders engaged in medicines decision making around what constitutes an “essential” medicine, and how the Essential Medicines List (EML) concept functions in a high income country context.Methods
In-depth qualitative semi-structured interviews were conducted with 32 Australian stakeholders, recognised as decision makers, leaders or advisors in the area of medicines reimbursement or supply chain management. Participants were recruited from government, pharmaceutical industry, pharmaceutical wholesale/distribution companies, medicines non-profit organisations, academic health disciplines, hospitals, and consumer groups. Perspectives on the definition and application of the EML concept in a high income country context were thematically analysed using grounded theory approach.Findings
Stakeholders found it challenging to describe the EML concept in the Australian context because many perceived it was generally used in resource scarce settings. Stakeholders were unable to distinguish whether nationally reimbursed medicines were essential medicines in Australia. Despite frequent generic drug shortages and high prices paid by consumers, many struggled to describe how the EML concept applied to Australia. Instead, broad inclusion of consumer needs, such as rare and high cost medicines, and consumer involvement in the decision making process, has led to expansive lists of nationally subsidised medicines. Therefore, improved communication and coordination is needed around shared interests between stakeholders regarding how medicines are prioritised and guaranteed in the supply chain.Conclusions
This study showed that decision-making in Australia around reimbursement of medicines has strayed from the fundamental utilitarian concept of essential medicines. Many stakeholders involved in medicine reimbursement decisions and management of the supply chain did not consider the EML concept in their approach. The wide range of views of what stakeholders considered were essential medicines, challenges whether the EML concept is out-dated or underutilised in high income countries. 相似文献947.
Sarah J. Dunstan Trinh Thi Bich Tram Guy E. Thwaites Tran Thi Hong Chau Nguyen Hoan Phu Tran Tinh Hien Jeremy J. Farrar Marcel Wolbers Nguyen Thi Hoang Mai 《PloS one》2015,10(3)
Adjunctive dexamethasone saves lives in the treatment of tuberculous meningitis but this response is influenced by the patient’s LTA4H genotype. Despite less certain benefit, adjunctive dexamethasone is also frequently used in the treatment of pyogenic bacterial meningitis, but the influence of LTA4H genotype on outcomes has not been previously investigated. We genotyped the LTA4H promoter region SNP (rs17525495) in 390 bacterial meningitis patients and 751 population controls. rs17525495 was associated with susceptibility to bacteriologically confirmed bacterial meningitis (P = 0.01, OR 1.27 95% confidence interval [CI] 1.05–1.54) but did not influence clinical presentation, disease severity or survival following dexamethasone treatment. 相似文献
948.
Novel K3V2(PO4)3/C Bundled Nanowires as Superior Sodium‐Ion Battery Electrode with Ultrahigh Cycling Stability 下载免费PDF全文
Xuanpeng Wang Chaojiang Niu Jiashen Meng Ping Hu Xiaoming Xu Xiujuan Wei Liang Zhou Kangning Zhao Wen Luo Mengyu Yan Liqiang Mai 《Liver Transplantation》2015,5(17)
Sodium‐ion battery has captured much attention due to the abundant sodium resources and potentially low cost. However, it suffers from poor cycling stability and low diffusion coefficient, which seriously limit its widespread application. Here, K3V2(PO4)3/C bundled nanowires are fabricated usinga facile organic acid‐assisted method. With a highly stable framework, nanoporous structure, and conductive carbon coating, the K3V2(PO4)3/C bundled nanowires manifest excellent electrochemical performances in sodium‐ion battery. A stable capacity of 119 mAh g?1 can be achieved at 100 mA g?1. Even at a high current density of 2000 mA g?1, 96.0% of the capacity can be retained after 2000 charge–discharge cycles. Comparing with K3V2(PO4)3/C blocks, the K3V2(PO4)3/C bundled nanowires show significantly improved cycling stability. This work provides a facile and effective approach to enhance the electrochemical performance of sodium‐ion batteries. 相似文献
949.
Sodium‐Ion Batteries: Novel K3V2(PO4)3/C Bundled Nanowires as Superior Sodium‐Ion Battery Electrode with Ultrahigh Cycling Stability (Adv. Energy Mater. 17/2015) 下载免费PDF全文
950.